Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.01−0.37 (-10.81%)
Close on Nov 17, 2026Market cap $58.22MP/E –Yield –
Corbus Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Corbus Pharmaceuticals's price to sales ratio was 135.6× on Jul 29, 2022, against 60.7× a year earlier. Over the last 5 years it ranged from 8.5× to 169.0×, with a median of 75.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 135.6× | +85.5 |
| 2021 | Dec 31, 2021 | 50.1× | +32.5 |
| 2020 | Dec 31, 2020 | 17.6× | +7.6 |
| 2019 | Dec 31, 2019 | 9.9× | −105.5 |
| 2018 | Dec 31, 2018 | 115.5× | −11.2 |
| 2017 | Dec 29, 2017 | 126.7× | −69.0 |
| 2016 | Dec 30, 2016 | 195.6× | – |
See a number that looks wrong?